Pharmaceutical composition for the prevention and treatment of non-alcoholic steatohepatitis, liver fibrosis and cirrhosis containing an adenosine derivative
A pharmaceutical composition for preventing or treating liver disease is provided. The pharmaceutical composition for preventing or treating liver disease includes a compound represented by Formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient.肝疾患の予防または治療用薬学的組成物が提供される。肝疾患の予防または治療用薬学的組成物は、化学式1で表される化合物またはその薬学的に許容可能な塩を有効成分として含む。